These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9774565)

  • 1. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
    De Logu A; Williamson RA; Rozenshteyn R; Ramiro-Ibañez F; Simpson CD; Burton DR; Sanna PP
    J Clin Microbiol; 1998 Nov; 36(11):3198-204. PubMed ID: 9774565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
    Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
    J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
    Däumer MP; Schneider B; Giesen DM; Aziz S; Kaiser R; Kupfer B; Schneweis KE; Schneider-Mergener J; Reineke U; Matz B; Eis-Hübinger AM
    Med Microbiol Immunol; 2011 May; 200(2):85-97. PubMed ID: 20931340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
    Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the antibody neutralization of herpes simplex virus.
    Lee CC; Lin LL; Chan WE; Ko TP; Lai JS; Wang AH
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1935-45. PubMed ID: 24100313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies.
    Ishizaka ST; Piacente P; Silva J; Mishkin EM
    J Infect Dis; 1995 Oct; 172(4):1108-11. PubMed ID: 7561190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.
    Peng T; Ponce-de-Leon M; Jiang H; Dubin G; Lubinski JM; Eisenberg RJ; Cohen GH
    J Virol; 1998 Jan; 72(1):65-72. PubMed ID: 9420201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection.
    Nicola AV; Peng C; Lou H; Cohen GH; Eisenberg RJ
    J Virol; 1997 Apr; 71(4):2940-6. PubMed ID: 9060653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.
    Sanna PP; De Logu A; Williamson RA; Hom YL; Straus SE; Bloom FE; Burton DR
    Virology; 1996 Jan; 215(1):101-6. PubMed ID: 8553581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
    Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
    J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria.
    Cattani P; Rossolini GM; Cresti S; Santangelo R; Burton DR; Williamson RA; Sanna PP; Fadda G
    J Clin Microbiol; 1997 Jun; 35(6):1504-9. PubMed ID: 9163470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
    J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
    Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
    J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1.
    Grabowska A; Jameson C; Laing P; Jeansson S; Sj Gren-Jansson E; Taylor J; Cunningham A; Irving WL
    J Gen Virol; 1999 Jul; 80 ( Pt 7)():1789-1798. PubMed ID: 10423148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.
    Ikoma M; Liljeqvist JA; Groen J; Glazenburg KL; The TH; Welling-Wester S
    J Clin Microbiol; 2002 Jul; 40(7):2526-32. PubMed ID: 12089274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.
    Krawczyk A; Arndt MA; Grosse-Hovest L; Weichert W; Giebel B; Dittmer U; Hengel H; Jäger D; Schneweis KE; Eis-Hübinger AM; Roggendorf M; Krauss J
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6760-5. PubMed ID: 23569258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries.
    Sanna PP; Williamson RA; De Logu A; Bloom FE; Burton DR
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6439-43. PubMed ID: 7604009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.